Gene: PINK1
Official Full Name: PTEN induced kinase 1provided by HGNC
Gene Summary: This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00485 | PINK1 Knockout cell line (HEK293) | Human | PINK1 | 1:3~1:6 | Negative | Online Inquiry |
KO02999 | PINK1 Knockout cell line (HeLa) | Human | PINK1 | 1:3~1:6 | Negative | Online Inquiry |
KO03000 | PINK1 Knockout cell line (HCT 116) | Human | PINK1 | 1:2~1:4 | Negative | Online Inquiry |
KO03001 | PINK1 Knockout cell line (A549) | Human | PINK1 | 1:3~1:4 | Negative | Online Inquiry |
PINK1 Gene Knockout Cell Lines are genetically engineered cell models specifically designed to lack the PINK1 gene, which is integral to mitochondrial quality control and cellular homeostasis. PINK1 (PTEN-induced putative kinase 1) plays a crucial role in protecting cells from stress-induced mitochondrial dysfunction and is linked to the pathogenesis of neurodegenerative diseases, particularly Parkinson's disease. The knockout of this gene leads to compromised mitochondrial integrity and heightened sensitivity to cellular stress, providing researchers with valuable insights into the pathways involved in mitochondria-mediated cellular signaling and apoptosis.
These cell lines are pivotal tools for studying the mechanisms of PINK1 in maintaining mitochondrial function and its implications in neurodegeneration. By utilizing these models, scientists can explore the cellular responses to various stressors, investigate the effects of pharmacological agents aimed at ameliorating mitochondrial dysfunction, and identify potential therapeutic targets for intervening in diseases associated with PINK1 dysregulation. Their application spans basic research, translational studies, and drug development, making them versatile in various contexts.
What sets our PINK1 Gene Knockout Cell Lines apart is their meticulous design and validation, ensuring consistent performance and reproducibility. Compared to other cell lines that may not fully recapitulate the PINK1 knockout phenotype, our lines provide a reliable and specifically tailored framework for experimental manipulations. Researchers and clinicians can expect increased robustness and efficiency in their studies with our product, which ultimately translates into higher-quality data and enhanced research outcomes.
By leveraging our extensive expertise in genetic engineering and cell biology, we deliver high-quality biological products that meet the rigorous demands of modern scientific research. Our commitment to innovation and excellence positions us as a trusted partner in advancing your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.